[KTTA] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[KTTA] Pasithea Therapeutics Corp.
Announcement Date
14-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -152.67%
YoY- -200.52%
Quarter Report
KTTA's Result
KTTA's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 0 0 241 219 14 14 15 -
PBT -3,598 -3,266 -5,118 -4,191 -2,658 -1,574 630 -
Tax -65 271,869 -1,215 730 -843 -1,616 0 -
NP -3,763 -275,135 -3,902 -4,586 -1,815 41 630 -
Tax Rate - - - - - - -0.00% -
Total Cost 3,763 275,135 4,143 4,805 1,829 -28 -615 -
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin 0.00 0.00 -1,621.19 -2,097.88 -13,364.21 302.78 4,183.53 -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -2.88 -211.05 -3.00 -3.45 -0.08 0.00 0.06 -
EPS Diluted -2.88 -211.05 -3.00 -3.45 -0.08 0.00 0.06 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.